<ul>
<li>5 只高收益股票，可能有助于缓解市场波动</li>
</ul>
<p>高乐氏公司（NYSE:CLX - 免费报告）- Zacks Research 的研究分析师在 5 月 14 日星期四向投资者发布的报告中下调了对高乐氏 2026 财年每股收益的预期。Zacks Research 分析师团队现在预测该公司将发布 5.50 美元的每股收益，低于之前的 5.95 美元的预期。Zacks Research 目前对该股票的评级为 “强烈卖出”。市场普遍预计高乐氏当前全年的每股收益为 5.63 美元。Zacks Research 还对高乐氏 2026 财年第四季度的每股收益预期为 1.62 美元，2027 财年第一季度的每股收益为 1.28 美元，2027 财年第二季度的每股收益为 1.44 美元，2027 财年第三季度的每股收益为 1.57 美元，2027 财年第四季度的每股收益为 1.71 美元，2027 财年每股收益为 6.00 美元，2028 财年第一季度的每股收益为 1.28 美元，2028 财年第二季度的每股收益为 1.59 美元，2028 财年第三季度的每股收益为 1.76 美元，2028 财年每股收益为 6.36 美元。</p>
<p>高乐氏（NYSE:CLX - 获取免费报告）最近在 4 月 30 日星期四发布了季度财报。该公司报告季度每股收益为 1.64 美元，超出分析师普遍预期的 1.55 美元，超出幅度为 0.09 美元。该公司在本季度的收入为 16.7 亿美元，而市场普遍预期的收入为 16.7 亿美元。高乐氏的股本回报率为 443.64%，净利润率为 11.18%。与去年同期相比，该公司的收入增长了 0.1%。去年同期，该公司每股收益为 1.45 美元。高乐氏已将其 2026 财年的指导目标设定为每股收益 5.450-5.650。</p>
<ul>
<li>3 只防御性股票，适合在经济不确定性持续时购买</li>
</ul>
<p>其他研究分析师最近也对该公司发布了报告。高盛集团在 5 月 1 日星期五的研究报告中重申了对高乐氏的 “卖出” 评级，并给出了 83.00 美元的目标价。花旗集团在 5 月 1 日星期五的研究报告中将高乐氏的目标价从 110.00 美元下调至 97.00 美元，并对该公司设定了 “中性” 评级。Weiss Ratings 在 4 月 13 日星期一的研究报告中将高乐氏的评级从 “卖出（d+）” 上调至 “持有（c-）”。Evercore 在 5 月 1 日星期五的研究报告中重申了对高乐氏的 “表现不佳” 评级，并给出了 110.00 美元的目标价。最后，Jefferies Financial Group 在 5 月 4 日星期一的研究报告中将高乐氏的目标价从 139.00 美元下调至 125.00 美元，并对该公司设定了 “买入” 评级。一位分析师对该股票给予了买入评级，十一位分析师给予了持有评级，五位分析师给予了卖出评级。根据 MarketBeat 的数据，该公司目前的平均评级为 “减持”，平均目标价为 103.40 美元。</p>
<p><strong>获取我们关于 CLX 的最新研究报告</strong></p>
<h2>高乐氏股票上涨 2.6%</h2>
<ul>
<li>3 只提高分红的股票——并用业绩支持这一点</li>
</ul>
<p>CLX 股票在星期二开盘价为 92.84 美元。该公司的速动比率为 0.65，流动比率为 0.84，债务与股本比率为 27.03。该公司的 50 日移动平均价格为 101.58 美元，200 日移动平均价格为 106.75 美元。该公司的市值为 112.3 亿美元，市盈率为 15.07，市盈率/增长比率为 0.47，贝塔值为 0.59。高乐氏的 12 个月低点为 84.70 美元，12 个月高点为 136.69 美元。</p>
<h2>机构资金流入和流出</h2>
<p>几家对冲基金和其他机构投资者最近对该公司的持仓进行了调整。Haverford Trust Co 在第四季度将其在高乐氏的股份增加了 2.8%。Haverford Trust Co 目前拥有 3,070 股该公司的股票，价值 310,000 美元，此前在该期间内增持了 84 股。Field &amp; Main Bank 在第四季度将其在高乐氏的股份增加了 3.3%。Field &amp; Main Bank 目前拥有 3,100 股该公司的股票，价值 313,000 美元，此前在该期间内增持了 100 股。Golden State Wealth Management LLC 在第四季度将其在高乐氏的持股增加了 28.2%。Golden State Wealth Management LLC 目前拥有 454 股该公司的股票，价值 46,000 美元，此前在上个季度增持了 100 股。Fisher Asset Management LLC 在第三季度将其在高乐氏的股份增加了 1.7%。Fisher Asset Management LLC 目前拥有 6,053 股该公司的股票，价值 746,000 美元，此前在该期间内增持了 102 股。最后，Kestra Private Wealth Services LLC 在第一季度将其在高乐氏的股份增加了 1.8%。Kestra Private Wealth Services LLC 目前拥有 5,957 股该公司的股票，价值 617,000 美元，此前在该期间内增持了 104 股。78.53% 的股票目前由机构投资者持有。</p>
<h2>高乐氏的内部活动</h2>
<p>在其他高乐氏新闻中，董事 Pierre R. Breber 于 5 月 5 日星期二购买了 5,000 股高乐氏股票。该股票的平均购买成本为每股 85.82 美元，总交易额为 429,100.00 美元。购买后，该董事持有该公司 18,000 股股票，价值 1,544,760 美元。此次交易使其持股增加了 38.46%。该购买在向证券交易委员会的法律文件中披露，文件可通过此超链接访问。公司内部人士持有该公司 0.63% 的股票。</p>
<h2>高乐氏分红公告</h2>
<p>该公司最近还宣布了一项季度分红，该分红于 5 月 8 日星期五支付。4 月 22 日星期三的股东获得了每股 1.24 美元的分红。这相当于每年 4.96 美元的分红和 5.3% 的分红收益率。除息日为 4 月 22 日星期三。高乐氏的派息比率目前为 80.52%。</p>
<h2>更多高乐氏新闻</h2>
<p>以下是本周影响高乐氏的主要新闻故事：</p>
<ul>
<li>积极情绪：MarketWatch 指出，Clorox 股票在强劲的交易日中表现优于同行，表明投资者在情绪改善时仍在向该股票轮动。Clorox 公司的股票在强劲的交易日中表现优于竞争对手。</li>
<li>中性情绪：富国银行将 Clorox 的目标股价从 100 美元下调至 95 美元，同时维持平等权重评级，表明谨慎但仍暗示当前水平的上涨空间有限。富国银行分析师将 Clorox NYSE: CLX 的目标股价下调至 95.00 美元。</li>
<li>消极情绪：Zacks Research 将 Clorox 的 2026 财年每股收益预期下调至 5.50 美元，低于 5.95 美元，反映出近期利润预期的疲软。</li>
<li>消极情绪：该公司还将 2027 财年的收益预期从 6.74 美元下调至 6.00 美元，将 2028 财年的收益预期从 7.23 美元下调至 6.36 美元，并削减了多个季度的预测，包括 2026 年第四季度、2027 年第一季度、2027 年第二季度和 2027 年第四季度。</li>
<li>消极情绪：Zacks Research 维持 “强烈卖出” 评级，尽管 Clorox NYSE: CLX 的消费品特征稳定，但仍强化了对其的看跌情绪。</li>
</ul>
<h2>Clorox 公司简介</h2>
<p>(获取免费报告)</p>
<p>Clorox 公司是领先的消费和专业产品制造商和营销商，旨在帮助人们照顾家庭，过上健康、可持续的生活。其产品组合涵盖清洁和家庭用品、食品和饮料、水过滤系统和猫砂，服务于零售和机构客户。该公司的旗舰漂白剂和消毒产品在美国及许多国际市场上广为人知，帮助防止细菌在家庭、医院、学校和企业中的传播。</p>
<p>Clorox 的多样化品牌阵容包括液体漂白剂和表面清洁剂、环保清洁工具、食品保存和准备用品、炭烤炉和木炭、特色食品和饮料、宠物护理产品以及个人护理系列。</p>
<h2>推荐故事</h2>
<ul>
<li>五只我们更看好的股票，胜过 Clorox</li>
<li>Dillard’s 发布了巨大的盈利超预期——那么为什么反弹会消退？</li>
<li>为什么特朗普的亚马逊股票出售可能根本无关紧要</li>
<li>为什么应用光电子股票可能接近转折点</li>
<li>从高收益到高增长：三只提升股息的股票</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNMWA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="650" height="325" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNMWA"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1000 美元在 Clorox 吗？</h2>
<p>在考虑 Clorox 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Clorox 并不在名单上。</p>
<p>虽然 Clorox 目前在分析师中获得了减持评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

高乐氏

日常消费品 ETF - SPDR

日常消费品 ETF - Vanguard

全球必需消费品股指数 ETF - iShares

食品饮料 ETF - PowerShares

<p>Zacks Research 将 Clorox 的 2026 财年每股收益预期从 $5.95 下调至 $5.50，维持 “强烈卖出” 评级。市场对 Clorox 当前全财年每股收益的共识预期为 $5.63。Clorox 最近的季度每股收益为 $1.64，超出预期。分析师的评级各不相同，其中一位为 “买入”，十一位为 “持有”，五位为 “卖出”。该股票开盘价为 $92.84，市值为 112.3 亿美元</p>

<ul>
<li>5 High-Yield Stocks That Could Help Cushion Market Volatility</li>
</ul>
<div class="lb-trans"><ul>
<li>5 只高收益股票，可能有助于缓解市场波动</li>
</ul>
</div><p>The Clorox Company (NYSE:CLX - Free Report) - Research analysts at Zacks Research lowered their FY2026 earnings per share estimates for Clorox in a note issued to investors on Thursday, May 14th. Zacks Research analyst Team now forecasts that the company will post earnings per share of $5.50 for the year, down from their prior estimate of $5.95. Zacks Research currently has a &#34;Strong Sell&#34; rating on the stock. The consensus estimate for Clorox's current full-year earnings is $5.63 per share. Zacks Research also issued estimates for Clorox's Q4 2026 earnings at $1.62 EPS, Q1 2027 earnings at $1.28 EPS, Q2 2027 earnings at $1.44 EPS, Q3 2027 earnings at $1.57 EPS, Q4 2027 earnings at $1.71 EPS, FY2027 earnings at $6.00 EPS, Q1 2028 earnings at $1.28 EPS, Q2 2028 earnings at $1.59 EPS, Q3 2028 earnings at $1.76 EPS and FY2028 earnings at $6.36 EPS.</p>
<div class="lb-trans"><p>高乐氏公司（NYSE:CLX - 免费报告）- Zacks Research 的研究分析师在 5 月 14 日星期四向投资者发布的报告中下调了对高乐氏 2026 财年每股收益的预期。Zacks Research 分析师团队现在预测该公司将发布 5.50 美元的每股收益，低于之前的 5.95 美元的预期。Zacks Research 目前对该股票的评级为 “强烈卖出”。市场普遍预计高乐氏当前全年的每股收益为 5.63 美元。Zacks Research 还对高乐氏 2026 财年第四季度的每股收益预期为 1.62 美元，2027 财年第一季度的每股收益为 1.28 美元，2027 财年第二季度的每股收益为 1.44 美元，2027 财年第三季度的每股收益为 1.57 美元，2027 财年第四季度的每股收益为 1.71 美元，2027 财年每股收益为 6.00 美元，2028 财年第一季度的每股收益为 1.28 美元，2028 财年第二季度的每股收益为 1.59 美元，2028 财年第三季度的每股收益为 1.76 美元，2028 财年每股收益为 6.36 美元。</p>
</div><p>Clorox (NYSE:CLX - Get Free Report) last posted its quarterly earnings results on Thursday, April 30th. The company reported $1.64 earnings per share for the quarter, beating analysts' consensus estimates of $1.55 by $0.09. The firm had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.67 billion. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The business's revenue was up .1% compared to the same quarter last year. During the same period last year, the company earned $1.45 earnings per share. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS.</p>
<div class="lb-trans"><p>高乐氏（NYSE:CLX - 获取免费报告）最近在 4 月 30 日星期四发布了季度财报。该公司报告季度每股收益为 1.64 美元，超出分析师普遍预期的 1.55 美元，超出幅度为 0.09 美元。该公司在本季度的收入为 16.7 亿美元，而市场普遍预期的收入为 16.7 亿美元。高乐氏的股本回报率为 443.64%，净利润率为 11.18%。与去年同期相比，该公司的收入增长了 0.1%。去年同期，该公司每股收益为 1.45 美元。高乐氏已将其 2026 财年的指导目标设定为每股收益 5.450-5.650。</p>
</div><ul>
<li>3 Defensive Stocks to Buy as Economic Uncertainty Lingers</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只防御性股票，适合在经济不确定性持续时购买</li>
</ul>
</div><p>Other research analysts also recently issued reports about the company. The Goldman Sachs Group restated a &#34;sell&#34; rating and issued a $83.00 price target on shares of Clorox in a research note on Friday, May 1st. Citigroup decreased their price target on Clorox from $110.00 to $97.00 and set a &#34;neutral&#34; rating for the company in a research note on Friday, May 1st. Weiss Ratings upgraded Clorox from a &#34;sell (d+)&#34; rating to a &#34;hold (c-)&#34; rating in a research note on Monday, April 13th. Evercore restated an &#34;underperform&#34; rating and issued a $110.00 price target on shares of Clorox in a research note on Friday, May 1st. Finally, Jefferies Financial Group decreased their price target on Clorox from $139.00 to $125.00 and set a &#34;buy&#34; rating for the company in a research note on Monday, May 4th. One analyst has rated the stock with a Buy rating, eleven have given a Hold rating and five have given a Sell rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of &#34;Reduce&#34; and an average target price of $103.40.</p>
<div class="lb-trans"><p>其他研究分析师最近也对该公司发布了报告。高盛集团在 5 月 1 日星期五的研究报告中重申了对高乐氏的 “卖出” 评级，并给出了 83.00 美元的目标价。花旗集团在 5 月 1 日星期五的研究报告中将高乐氏的目标价从 110.00 美元下调至 97.00 美元，并对该公司设定了 “中性” 评级。Weiss Ratings 在 4 月 13 日星期一的研究报告中将高乐氏的评级从 “卖出（d+）” 上调至 “持有（c-）”。Evercore 在 5 月 1 日星期五的研究报告中重申了对高乐氏的 “表现不佳” 评级，并给出了 110.00 美元的目标价。最后，Jefferies Financial Group 在 5 月 4 日星期一的研究报告中将高乐氏的目标价从 139.00 美元下调至 125.00 美元，并对该公司设定了 “买入” 评级。一位分析师对该股票给予了买入评级，十一位分析师给予了持有评级，五位分析师给予了卖出评级。根据 MarketBeat 的数据，该公司目前的平均评级为 “减持”，平均目标价为 103.40 美元。</p>
</div><p><strong>Get Our Latest Research Report on CLX</strong></p>
<div class="lb-trans"><p><strong>获取我们关于 CLX 的最新研究报告</strong></p>
</div><h2>Clorox Stock Up 2.6%</h2>
<div class="lb-trans"><h2>高乐氏股票上涨 2.6%</h2>
</div><ul>
<li>3 Dividend Stocks Raising Payouts—and Backing It Up With Results</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只提高分红的股票——并用业绩支持这一点</li>
</ul>
</div><p>CLX stock opened at $92.84 on Tuesday. The company has a quick ratio of 0.65, a current ratio of 0.84 and a debt-to-equity ratio of 27.03. The business has a 50 day moving average price of $101.58 and a two-hundred day moving average price of $106.75. The company has a market cap of $11.23 billion, a price-to-earnings ratio of 15.07, a P/E/G ratio of 0.47 and a beta of 0.59. Clorox has a twelve month low of $84.70 and a twelve month high of $136.69.</p>
<div class="lb-trans"><p>CLX 股票在星期二开盘价为 92.84 美元。该公司的速动比率为 0.65，流动比率为 0.84，债务与股本比率为 27.03。该公司的 50 日移动平均价格为 101.58 美元，200 日移动平均价格为 106.75 美元。该公司的市值为 112.3 亿美元，市盈率为 15.07，市盈率/增长比率为 0.47，贝塔值为 0.59。高乐氏的 12 个月低点为 84.70 美元，12 个月高点为 136.69 美元。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>机构资金流入和流出</h2>
</div><p>Several hedge funds and other institutional investors have recently made changes to their positions in the business. Haverford Trust Co boosted its stake in shares of Clorox by 2.8% during the 4th quarter. Haverford Trust Co now owns 3,070 shares of the company's stock worth $310,000 after acquiring an additional 84 shares during the period. Field &amp; Main Bank boosted its stake in shares of Clorox by 3.3% during the 4th quarter. Field &amp; Main Bank now owns 3,100 shares of the company's stock worth $313,000 after acquiring an additional 100 shares during the period. Golden State Wealth Management LLC lifted its holdings in Clorox by 28.2% during the 4th quarter. Golden State Wealth Management LLC now owns 454 shares of the company's stock worth $46,000 after purchasing an additional 100 shares during the last quarter. Fisher Asset Management LLC boosted its stake in Clorox by 1.7% in the 3rd quarter. Fisher Asset Management LLC now owns 6,053 shares of the company's stock valued at $746,000 after purchasing an additional 102 shares during the period. Finally, Kestra Private Wealth Services LLC boosted its stake in Clorox by 1.8% in the 1st quarter. Kestra Private Wealth Services LLC now owns 5,957 shares of the company's stock valued at $617,000 after purchasing an additional 104 shares during the period. 78.53% of the stock is currently owned by institutional investors.</p>
<div class="lb-trans"><p>几家对冲基金和其他机构投资者最近对该公司的持仓进行了调整。Haverford Trust Co 在第四季度将其在高乐氏的股份增加了 2.8%。Haverford Trust Co 目前拥有 3,070 股该公司的股票，价值 310,000 美元，此前在该期间内增持了 84 股。Field &amp; Main Bank 在第四季度将其在高乐氏的股份增加了 3.3%。Field &amp; Main Bank 目前拥有 3,100 股该公司的股票，价值 313,000 美元，此前在该期间内增持了 100 股。Golden State Wealth Management LLC 在第四季度将其在高乐氏的持股增加了 28.2%。Golden State Wealth Management LLC 目前拥有 454 股该公司的股票，价值 46,000 美元，此前在上个季度增持了 100 股。Fisher Asset Management LLC 在第三季度将其在高乐氏的股份增加了 1.7%。Fisher Asset Management LLC 目前拥有 6,053 股该公司的股票，价值 746,000 美元，此前在该期间内增持了 102 股。最后，Kestra Private Wealth Services LLC 在第一季度将其在高乐氏的股份增加了 1.8%。Kestra Private Wealth Services LLC 目前拥有 5,957 股该公司的股票，价值 617,000 美元，此前在该期间内增持了 104 股。78.53% 的股票目前由机构投资者持有。</p>
</div><h2>Insider Activity at Clorox</h2>
<div class="lb-trans"><h2>高乐氏的内部活动</h2>
</div><p>In other Clorox news, Director Pierre R. Breber bought 5,000 shares of Clorox stock in a transaction dated Tuesday, May 5th. The stock was bought at an average cost of $85.82 per share, for a total transaction of $429,100.00. Following the purchase, the director owned 18,000 shares of the company's stock, valued at $1,544,760. The trade was a 38.46% increase in their position. The purchase was disclosed in a legal filing with the Securities &amp; Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 0.63% of the company's stock.</p>
<div class="lb-trans"><p>在其他高乐氏新闻中，董事 Pierre R. Breber 于 5 月 5 日星期二购买了 5,000 股高乐氏股票。该股票的平均购买成本为每股 85.82 美元，总交易额为 429,100.00 美元。购买后，该董事持有该公司 18,000 股股票，价值 1,544,760 美元。此次交易使其持股增加了 38.46%。该购买在向证券交易委员会的法律文件中披露，文件可通过此超链接访问。公司内部人士持有该公司 0.63% 的股票。</p>
</div><h2>Clorox Dividend Announcement</h2>
<div class="lb-trans"><h2>高乐氏分红公告</h2>
</div><p>The firm also recently announced a quarterly dividend, which was paid on Friday, May 8th. Stockholders of record on Wednesday, April 22nd were paid a dividend of $1.24 per share. This represents a $4.96 annualized dividend and a dividend yield of 5.3%. The ex-dividend date was Wednesday, April 22nd. Clorox's payout ratio is currently 80.52%.</p>
<div class="lb-trans"><p>该公司最近还宣布了一项季度分红，该分红于 5 月 8 日星期五支付。4 月 22 日星期三的股东获得了每股 1.24 美元的分红。这相当于每年 4.96 美元的分红和 5.3% 的分红收益率。除息日为 4 月 22 日星期三。高乐氏的派息比率目前为 80.52%。</p>
</div><h2>More Clorox News</h2>
<div class="lb-trans"><h2>更多高乐氏新闻</h2>
</div><p>Here are the key news stories impacting Clorox this week:</p>
<div class="lb-trans"><p>以下是本周影响高乐氏的主要新闻故事：</p>
</div><ul>
<li>Positive Sentiment: MarketWatch noted Clorox stock outperformed peers in a strong trading session, suggesting investors are still rotating toward the name when sentiment improves. Clorox Co. stock outperforms competitors on strong trading day</li>
<li>Neutral Sentiment: Wells Fargo cut its price target on Clorox to $95 from $100 while keeping an equal-weight rating, signaling caution but still implying limited upside from current levels. Clorox NYSE: CLX Price Target Cut to $95.00 by Analysts at Wells Fargo &amp; Company</li>
<li>Negative Sentiment: Zacks Research lowered its FY2026 earnings estimate for Clorox to $5.50 per share from $5.95, reflecting softer near-term profit expectations.</li>
<li>Negative Sentiment: The firm also cut FY2027 earnings to $6.00 from $6.74, FY2028 to $6.36 from $7.23, and trimmed multiple quarterly forecasts, including Q4 2026, Q1 2027, Q2 2027, and Q4 2027.</li>
<li>Negative Sentiment: Zacks Research maintained a “Strong Sell” rating, reinforcing bearish sentiment around <strong>Clorox NYSE: CLX</strong> despite its stable consumer-staples profile.</li>
</ul>
<div class="lb-trans"><ul>
<li>积极情绪：MarketWatch 指出，Clorox 股票在强劲的交易日中表现优于同行，表明投资者在情绪改善时仍在向该股票轮动。Clorox 公司的股票在强劲的交易日中表现优于竞争对手。</li>
<li>中性情绪：富国银行将 Clorox 的目标股价从 100 美元下调至 95 美元，同时维持平等权重评级，表明谨慎但仍暗示当前水平的上涨空间有限。富国银行分析师将 Clorox NYSE: CLX 的目标股价下调至 95.00 美元。</li>
<li>消极情绪：Zacks Research 将 Clorox 的 2026 财年每股收益预期下调至 5.50 美元，低于 5.95 美元，反映出近期利润预期的疲软。</li>
<li>消极情绪：该公司还将 2027 财年的收益预期从 6.74 美元下调至 6.00 美元，将 2028 财年的收益预期从 7.23 美元下调至 6.36 美元，并削减了多个季度的预测，包括 2026 年第四季度、2027 年第一季度、2027 年第二季度和 2027 年第四季度。</li>
<li>消极情绪：Zacks Research 维持 “强烈卖出” 评级，尽管 Clorox NYSE: CLX 的消费品特征稳定，但仍强化了对其的看跌情绪。</li>
</ul>
</div><h2>Clorox Company Profile</h2>
<div class="lb-trans"><h2>Clorox 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(获取免费报告)</p>
</div><p>The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company's flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.</p>
<div class="lb-trans"><p>Clorox 公司是领先的消费和专业产品制造商和营销商，旨在帮助人们照顾家庭，过上健康、可持续的生活。其产品组合涵盖清洁和家庭用品、食品和饮料、水过滤系统和猫砂，服务于零售和机构客户。该公司的旗舰漂白剂和消毒产品在美国及许多国际市场上广为人知，帮助防止细菌在家庭、医院、学校和企业中的传播。</p>
</div><p>Clorox's diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.</p>
<div class="lb-trans"><p>Clorox 的多样化品牌阵容包括液体漂白剂和表面清洁剂、环保清洁工具、食品保存和准备用品、炭烤炉和木炭、特色食品和饮料、宠物护理产品以及个人护理系列。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推荐故事</h2>
</div><ul>
<li>Five stocks we like better than Clorox</li>
<li>Dillard’s Posted a Huge Earnings Beat—So Why Did the Rally Fade?</li>
<li>Why Trump’s Amazon Stock Sale May Not Matter at All</li>
<li>Why Applied Optoelectronics Stock May Be Near a Turning Point</li>
<li>From High-Yield to High-Growth: 3 Stocks Boosting Dividends</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过 Clorox</li>
<li>Dillard’s 发布了巨大的盈利超预期——那么为什么反弹会消退？</li>
<li>为什么特朗普的亚马逊股票出售可能根本无关紧要</li>
<li>为什么应用光电子股票可能接近转折点</li>
<li>从高收益到高增长：三只提升股息的股票</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNMWA" alt="" original-src="https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx?Prefix=NYSE&amp;Symbol=CLX"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Clorox Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在 Clorox 吗？</h2>
</div><p>Before you consider Clorox, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Clorox 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Clorox 并不在名单上。</p>
</div><p>While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Clorox 目前在分析师中获得了减持评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Zacks Research 发布了高乐氏 2026 财年的收益预测